UMIN ID: UMIN000001276
Registered date:01/08/2008
Japan Home versus Office Measurement Evaluation for Heart Rate study
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Essential Hypertension |
Date of first enrollment | 2008/08/01 |
Target sample size | 50 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Administration of beta blockers |
Outcome(s)
Primary Outcome | Home heart rate |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 80years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1.Taking beta blockers, anti arrhythmic drug, cardio tonic, or bradycardiac drug within a month, 2.Contraindications or hypersensitivity to beta blockers use, 3.Pulmonary disease, severe diabetes mellitus, or hyperthyroidism, 4.Malignant hypertension, 5.Secondary hypertension, 6.Not available for informed consent, 7.Participating other intervention trials, 8.Severe complications leading to stop this study, 9.Other inappropriate conditions judged by each physician |
Related Information
Primary Sponsor | Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | 21st COE program 'Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation', Tohoku University Graduate School of Pharmaceutical Sciences |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | Japan |
Telephone | |
iyaku-kifu@mail.tains.tohoku.ac.jp | |
Affiliation | Tohoku University Graduate School of Pharmaceutical Sciences and Medicine Department of Clinical Pharmacology and Therapeutics |
scientific contact | |
Name | Imai Yutaka |
Address | 1-1 Seiryo-cho, Aoba-ku, Sendai, 980-8574, Japan. Japan |
Telephone | |
Affiliation | Tohoku University Graduate School of Pharmaceutical Sciences and Medicine Department of Clinical Pharmacology and Therapeutics |